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ABSTRACT 
 
The Role of the Bcl-X Gene a as Tumor Suppressor (April 2007) 
 
Farah E. McCorvey 
Department of Biomedical Science 
Texas A&M University 
 
Research Advisor: Dr. Edmund Rucker 
Department of Biomedical Sciences 
 
Cell death, also known as apoptosis, is necessary in order to maintain a healthy tissue 
state.  When cell death doesn’t occur and cells grow uncontrollably, one pathological 
result is cancer.  One of the genes believed to regulate cell death and act as a tumor 
suppressor in certain types of cancers (e.g. breast cancer) is the gene Bcl-x.  I seek to 
determine if Bcl-x is an effective tumor suppressor in hopes that it may be used in gene 
targeting for treating breast cancer.  The methods of my project included quantitating the 
Beclin levels in breast cancer cell lines, transfecting Bcl-x in to the cells. Lastly, I 
induced apoptosis and analyzed the susceptibility of the cells to death. Our results 
showed that increased Bcl-x expression did not reduce this apoptotic induction. 
 
 
 
 
 
  iv 
 
Acknowledgements 
I would like to thank Dr. Rucker and all of the VTPP 485 and work study students that 
participated in this research project.   
 
  v 
NOMENCLATURE 
 
PCR Polymerase Chain Reaction 
RT PCR Reverse Transcriptase Polymerase Chain Reaction 
PCD Programmed Cell Death 
cDNA Complimentary Deoxyribonucleic acid 
C-terminus Carboxy Terminus 
GADPH Glyceraldehyde- 3 Phosphate Dehydrogenase 
PBS Phosphate- buffered Saline 
ul microliter 
ml milliliter 
nm nanometer 
mg milligram 
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CHAPTER I 
INTRODUCTION: PROGRAMMED CELL DEATH 
 
Cell death is a natural and necessary process.  Cells must continuously grow and die in 
order to maintain healthy tissue state.  If too many cells are present, improper 
development will occur, just as if too few cells are present.  One way cells maintain 
homeostasis is by programmed cell death (PCD). The two types of PCD are apoptosis 
(or cell suicide) and autophagic (or self- eating) cell death. They are two distinct 
mechanisms employed by cells to maintain balance within a given environment.  Though 
they each end in cell death, their characteristics and conditions are quite distinct.      
 
Apoptosis 
Apoptosis is an essential process of multicellular development.  Its role is to destroy 
excess, defective or potentially hazardous cells. In order for an organism to grow 
properly, millions of cells must die and be replaced with new cells everyday. The 
instrumental players in the mechanism of apoptosis are a protein family called caspases. 
These caspases are inactive precursor (zymogen) proteases with cysteine active-sites.  
Each caspase must first be activated by cleavage at two aspartic acids in its protein 
sequence. This activation is often carried out by previously activated caspase molecules.   
Once activated, the caspases are considered active enzymes. These enzymes begin 
apoptosis by cleaving specific target proteins within the cell.  They cleave proteins that 
support the cytoskeleton, the nuclear membrane, and other supporting structures inside 
_______________ 
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the cell.  They also free a DNA-degrading enzyme known as DNAse that cuts up DNA 
within the nucleus.   These events allow the cell to dismantle and shrink in size. The 
final change in an apoptotic cell occurs at the phospholipid membrane.  A negatively 
charged molecule known as phosphatidylserine marks the cell surface so that it may be 
ingested by neighboring phagocytes. Phagocytosis occurs quickly to ensure that the cell 
does not leak. (Yu et al., 2006).    
Regulation of apoptosis 
Though apoptosis is the process of cell death, there are many regulators in place that 
control this mechanism. An example of an external factor of apoptosis is simply the 
failure to receive the apoptosis suppressing signals from the environment.  The presence 
of these signals is necessary for survival in most of our cells. These “survival factors” 
bind to receptors on the cell surface that either block apoptosis promoters or activate 
apoptosis inhibitors.  An internal regulator of the apoptosis mechanism is the Bcl-2 gene 
family. The Bcl-2 family facilitates the release of the electron carrier, cytochrome c from 
the mitochondrial membrane into the cytoplasm.  Once in the cytoplasm, cytochrome c 
binds to an adaptor known as Apaf -1. This newly formed complex activates caspase-9, 
which leads to the surge caspase activation. This in turn speeds up the process of cell 
breakdown and apoptosis.  (Rodriguez-Enriquez et al., 2004; Marx, 2006)  
 
Autophagy                  
Autophagy is another process of cell degradation.  The difference between autophagy 
and apoptosis is that autophagy takes place entirely from within the cell.  Autophagy’s 
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key role is to recycle cellular components in times of environmental stress.  It is also 
important in cellular differentiation and in tissue repair.  When cells experience DNA 
damage, hypoxia, nutrient deficiencies, or any change in environmental conditions, the 
process of autophagy is triggered.  The process begins by sequestering organelles and 
cytosolic proteins in a double membrane structure called an autophagosome or 
autophagic vacuole.  The vacuole membrane then fuses with the cell’s lysosomes and 
releases the contents into the lumen of the lysosome.  The lysosome then degrades the 
contents thus recycling the cellular components. The recycled components can be used 
as building blocks for macromolecular synthesis and a source of energy that is necessary 
for the cell to survive during harsh conditions.   The process of autophagy can also help 
to eliminate damaged organelles within the cell without destroying the entire cell.  For 
this reason, autophagy has been thought to precede apoptosis and is a “last attempt” to 
save the cell.   When the situation exceeds autophagy’s capability, apoptosis is then 
triggered.  (Levine et al., 2004; Gozuacik and Kimichi, 2004; Marx, 2006) 
Regulation of autophagy 
Autophagy also has many regulatory mechanisms in place that maintain control, two of 
which are exhibited during cancer with Bcl- 2 and a gene called Beclin-1.  Beclin-1, a 
homologue of a yeast autophagy gene Apg6, was discovered by Beth Levine of UT 
Southwestern Medical Center in Dallas.  Levine’s team found that when Bcl-2 is bound 
to products of Beclin, autophagy was inhibited.  This suggests that Bcl-2 regulates 
autophagy activity during normal conditions so that autophagy takes place when 
necessary.  (Yue et al., 2006)  However, if Bcl-2 activity is excessive, autophagy will be 
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suppressed and damaged cells will continue to become malignant. Levine’s team also 
found that Beclin-1 was either deleted or expressed at very low levels in a high number 
of ovarian, prostate, and breast cancers.  They performed a subsequent experiment in 
which they knocked out a single copy of the Beclin-1 gene in mice.  The results showed 
that mice demonstrated a decrease in autophagic activity, an increase in breast tumors 
and an increase in the occurrence of lymphoma and cancer of the liver and lung (Yue et 
al., 2003). From these observations, Beclin is presumed to be a tumor suppressor gene. 
Further experiments were done to test Beclin’s role as a regulator of autophagy. Beclin 
deficient mice were generated and examined. The results showed that those mice 
exhibited a decrease in the formation of autophagic vacuoles (Qu et al., 2003; Yue et al., 
2003).  Though Beclin is not essential for autophagosome formation, its loss does cause 
a decreased autophagic response.  Figure 1 show a schematic of the role of Beclin in the 
process of autophagy. 
 
Scope of project 
The purpose of this project is to determine the role of the Bcl-x gene in tumor 
suppression.  Our goal is to introduce Bcl-x into MCF-7 breast cancer cells that express 
Beclin at very low levels and to chemically induce apoptosis in the cells.   
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Figure 1. The process of autophagy. 
Autophagy and Beclin in the turnover of damaged proteins and organelles. In autophagy the cell 
membrane engulfs the cell’s components that need to be degraded which forms an autophagosme. Beclin-
1 aides in the formation of the autophagosome. A lysosyme then fuses with the autophagosome and the 
cellular components are degraded by the enzymes within the lysosome (image reproduced as courtesy of 
HOPES). 
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CHAPTER II 
METHODS  
The first step of this project was to determine the level of Beclin expression in 
established MCF-7 breast cancer cell lines. We later transfected the cells with Bcl-x into 
the cells and induced apoptosis. 
 
Real-time reverse transcriptase PCR 
Real-Time PCR was performed on cDNA from a breast cancer cell panel using SYBR 
green chemistry on the ABI 7500.  Beclin expression was normalized to the 
housekeeping gene GAPDH.  
 
Transfection of MCF-7 cells  
MCF-7 cells were transfected with the Bcl-x expression plasmid.  This contained a Bcl-
x-GFP (green fluorescent protein) coding sequence that encoded for a Bcl-x-GFP fusion 
protein.  The coding sequence was controlled by a CMV (cytomegalovirus) promoter for 
high level expression.  For antibiotic selection, this plasmid also contained a neomycin 
cassette to select for transfected cells that had geneticin resistance.  The first step in 
transfection was to remove the media on the plates and replace it with 2.5 ml of fresh 
growth media (DMEM with 10% FBS). The transfection was done by adding 250 ul of 
serum free media to a clean 1.5ml eppendorf tube.  Then 7.5 ul of Mirus transfection 
solution was added to the tube and the mixture stood for 15 minutes. Next, 2.5 ul of 
Beclin DNA was added to each of the cell wells.  Lastly, the 44 ul of transfection 
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solution was added drop-wise to the cell wells. The cells were then incubated for 24 
hours, after which geneticin containing medium was added (DMEM with 10% FBS and 
500 ug/ml geneticin).  Selection was carried out for 2 weeks to establish stable 
transfectants. 
 
Cloning of transfected cells 
The geneticin-resistant transfected cells were cloned using sterile cloning disks.  The 
desired cell colonies were isolated with a marker on the bottom of the plate.  The media 
was removed and the plate was washed with 3 ml of PBS.  The cloning disks were 
dipped in 0.05% trypsin solution, placed on the on the plate and the plates were 
incubated for three minutes so that the cells would be transferred to the disk.  While the 
plates were incubating, 0.5 ml of fresh media were added to each well of a 24 well plate.  
After incubation the cloning disks were removed and placed into each of the wells of the 
new 24 well plate. After 24 hours the disks were removed from each of the wells and the 
cells were trypsinized and transferred to a larger culture dish. 
 
Apoptosis induction and detection 
The apoptosis inducer set I (Chemicon) was used to trigger apoptosis in our MCF-7 and 
Mcf-7/Bcl-x cell lines.  This set contained the following chemical inducers of apoptosis 
at 1000X concentrations:  actinomycin D, camptothecin, etoposide, cycloheximide, and 
dexamethasone.  Cells were treated with the specific inducer at a 1X concentration in 
DMEM for either 4 hours or 24 hours, and then assayed for the apoptosis.  We used a 
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Vybrant® Apoptosis Assay Kit to detect apoptosis in our cells. A negative control was 
prepared by incubating the cells that did not contain the inducing agent.  The cells were 
incubated and washed with cold PBS.  The Annexin-Binding Buffer was prepared by 
adding 1 ml of 5X Annexin- Binding Buffer to 4 ml of deionized water.  Next, a 
0.1mg/ml working solution of 7-AAD dye was prepared by adding 5 ul of 7 AAD stock 
solution to 45 ul of Annexin- Binding Buffer. The washed cells were centrifuged and the 
supernatant was removed.  The cells were resuspended in the 1X Annexin Binding 
Buffer.  Cell density was determined and the cells were diluted so that a 100 ul/ ml assay 
was prepared.   Next, 5 ul of Pacific Blue annexin V and 1 ul of AAD working solution 
was added to each of the 100 ul cell suspensions.  The cells were then incubated for 30 
minutes.  Next, 400 ul of Binding Buffer solution was mixed in gently and the samples 
were stored on ice.  Lastly, the cells were analyzed using flow cytometry and 
fluorescence emission was measured at 440 nm violet excitation and at 660 nm with 488 
nm excitation.  The cells were then separated into three groups: live cells with low level 
violet excitation and red fluorescence, apoptotic cells with high violet fluorescence and 
no red fluorescence, and necrotic cells with high level violet and high level red 
fluorescence.    
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CHAPTER III 
RESULTS 
 
RT- PCR results 
A panel of cells was chosen and RT-PCR was performed in order to determine the 
expression levels of Beclin. Figure 2 shows the relative expression levels of Beclin of 
the breast cancer cell panel. MCF-7 cells were shown to have one of the lowest 
expression levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Expression levels of Beclin. 
Relative Expression of levels of Beclin compared to GAPDH (a housekeeping gene) by real-time PCR 
SYBR green chemistry was used on cDNA template from a breast cancer cell panel. MCF-7, 21MT2, 
MDA453 cells had the lowest levels or expression. 
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MCF-7 cells over expressing Bcl-x-GFP 
Transfected MCF-7 cells were engineered to over express a Bcl-x-GFP fusion protein.  
These cells are shown to express the fusion protein as shown in Figure 3.  Fluorescence 
microscopy shows that GFP-expression localized to peri-nuclear staining in the cells, 
which is associated with the distribution of mitochondria.  This is expected since Bcl-x 
interacts with the mitochondrial membrane in providing resistance to the induction of 
apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: GFP labeled MCF-7 cells.  
This is an image of the results of a Fluorescence microscopy of stable MCF-7 cells engineered with a Bcl-
x-GFP transgene.  This transgene expresses a Bcl-x-GFP fusion protein for tracking Bcl-x within the cells. 
 
 
Apoptosis  
Out of the five apoptosis inducers tested, only two were able to initiate apoptosis at the 
concentrations tested: camptothecin and actinomycin D.  In addition, differences 
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between control (no inducer) and treatments were found after 24 hours but not 4 hours.  
Cell counts revealed a 4-fold reduction in the number of viable cells from camptothecin 
or actinomycin D treated cells versus controls.  Camptothecin inhibits nuclear 
topoisomerase, thus preventing DNA replication; in contrast, actinomycin D inhibits 
RNA synthesis.   Morphologically, treated cells contained pyknotic (condensed) nuclei 
and were detaching from the plates.  Surprisingly, Bcl-x over expression did not reduce 
this apoptotic induction. 
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CHAPTER IV 
SUMMARY AND FUTURE WORKS 
 
Bcl-x is vital for the regulation of autophagy and apoptosis by its interaction with the 
tumor suppressor protein Beclin.  When bcl-x is under expressed apoptosis does not 
occur and a damaged cell will continue to proliferate which can result in cancer.  We 
have selected MCF-7 cells that express Bcl-x at very low levels.  We transfected Bcl-x 
into MCF-7 cells, cloned those cells and tested their susceptibility to undergo cell death. 
After inducing apoptosis we found that Bcl-x over expression did not suppress apoptosis 
as suspected. This suggests that this type of apoptosis used did not initially engage the 
mitochnodria.    
 
Future works 
In the future we will focus on the specific gene Beclin-1 and determine which region of 
Beclin is most effective in tumor suppression.  We will subclone three fragments into 
vectors along with an inducible tetracycline into the system that will be transfected into 
MCF-7 cells.  Lastly, we will induce apoptosis and determine if full length Beclin or if 
one of the three fragments is most effective in tumor suppression.  We will compare 
these cells’ susceptibility to apoptosis. This information will allow us to better 
understand the link between the processes of autophagy and apoptosis, and the regions 
of Beclin that are necessary to provide tumor suppression; different gene targeting 
treatments for breast cancer can be developed from this research. 
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